Efficacy of Tocilizumab in COVID-19: Single-Center Experience

Table 3

Multivariable logistic regression model predicting hospital mortality in patients with COVID-19 infection received tocilizumab.

Variable	OR	95% CI	value
Age	1.020	0.995-1.045	0.115
SpO2 (%)^#	0.832	0.786-0.882	<0.001
Lymphocyte (10^3/mm^3)^#	0.322	0.132-0.788	0.013
CRP (mg/dL)^#	1.003	0.999-1.007	0.125
Temperature (°C)^#	1.257	0.830-1.904	0.280
Hypertension	2.594	1.341-5.019	0.005
Diabetes mellitus	2.961	1.472-5.959	0.002

^#At the first dose of tocilizumab. Statistically significant. OR: odds ratio; CI: confidence interval; CRP: C-reactive protein; SpO₂: oxygen saturation measured by pulse oximetry.